6.3.5.2. risk factors relapse. patients isup grade group > 2 combination epe (pt3a) particularly sv invasion (pt3b) and/or positive surgical margins high risk progression, high 50% five years . irrespective pt stage, number removed nodes [821-828], tumour volume within lns capsular perforation nodal metastases predictors early recurrence rp pn1 disease . ln density (defined ‘the percentage positive lns relation total number analysed/removed lns’) 20% found associated poor prognosis . number involved nodes seems major factor predicting relapse ; threshold considered less 3 positive nodes eplnd . however, prospective data needed defining definitive threshold value. 6.3.5.2.1. biomarker-based risk stratification radical prostatectomy decipher® gene signature consists 22-gene panel representing multiple biological pathways developed predict systemic progression definitive treatment. meta-analysis five studies analysed performance decipher® genomic classifier (gc) test men post-rp. authors showed multivariable analysis decipher® gc remained statistically significant predictor metastasis (hr: 1.30, 95% ci: 1.14–1.47, p < 0.001) per 0.1 unit increase score concluded independently improve prognostication patients post-rp within nearly clinicopathologic, demographic, treatment subgroups . sr evidence decipher® gc confirmed clinical utility test post-rp decision-making . studies needed establish best incorporate decipher® gc clinical decision-making.